🩸🌍The RADeep Network is now live on social media!
🔎What is #RADeep?
Established in 2017, RADeep is the European patient registry platform dedicated to rare anemia disorders (RADs), serving as an umbrella for both new and existing patient registries across Europe.
🎯Real-world evidence is only as strong as the data behind it.
Last week, RADeep brought together data entry teams from across Europe in Barcelona ,because building a reliable registry means investing in the people who make it possible.
radeepnetwork.eu/
🌍 We were pleased to welcome 14 participants from Belgium, Denmark, France, Greece, Italy, the Netherlands, Norway, Portugal, and Spain.
The session covered two critical areas: genotype data extraction and accurate recording of acute events
A dedicated session led by Dr. María del Mar Mañú Pereira, Head of the Rare Anemia Disorders Laboratory at @VHIR_ ) and Scientific Coordinator of ERN-EuroBloodNet, focused specifically on genotype data extraction and correct data entry practices.
📢We are looking for a Senior Scientific Coordinator to join the RADeep team!
👉 If you have experience in scientific project coordination and enjoy working in international environments, we would love to hear from you! lnkd.in/eqcphE42
📅 Deadline: 23/02/2026
📣 #Hiring alert!
We are looking for a motivated Biostatistician to join our Data Driven Team at @VHIR_ in Barcelona!
🔗 Excited about this role? Apply now and join our team! lnkd.in/enYKUK58
🤝It has been a highly active year for #RADeep Network, the European registry for rare anemias coordinated by @VHIR_ , with important contributions presented at the American Society of Hematology Annual Meeting.
⏰Final week to submit your abstract! The submission is still open for the @EHA_Hematology SWG Scientific Meeting on Bleeding and Platelet Disorders, to be held in Florence, Italy, April 9–11, 2026.
📝 Submit your abstract by December 21!
eurobloodnet.eu/news/697/eha…
Honoured to highlight María del Mar Mañú Pereira, Rare Anemias Lab Lead and ERN-EuroBloodNet Co-Coordinator, for her talk on ethical, data-driven AI in rare diseases at the XXXI National Congress of Health Law in Madrid.
📊Anna Collado at #ASH25 poster session “Thalassemia in europe: A cross-border real-world data analysis from the radeep registry”
This study presents the results of the first European dataset of thalassemia patients captured in the #RADeep Registry.
bit.ly/3XI2vuk
#RADeep is coordinated by Dr @mmanupe , Head of the Rare Anaemia Disorders Laboratory at @VHIR_ Vall d’Hebron Institute of Research (VHIR) and Scientific Coordinator of the @ERNEuroBloodNet (European Reference Network on Rare Hematological Diseases).
📣NEWS from the #ASH25! Sara Reidel is presenting “Data validation and quality framework for building a european multimodal real-world dataset for clinical outcome research in sickle cell disease” at the 67th ASH Annual Meeting.
🔗meetings-api.hematology.org/…#RADeep#hematology
🌍 This work presents a data validation and quality framework aligned with FAIR principles (Findable, Accessible, Interoperable, Reusable) and the European Medicines Agency recommendations, aimed at building a cross-border European SCD multi-modal real-world dataset.
#ASH25 Poster Session was also an excellent opportunity for members of the #RADeep Steering Committee & Data Access Committee to exchange insights and discuss challenges and perceptions regarding care, treatment access, and inclusion in clinical trials for people living with RADs
🩸Raffaella Colombatti, pediatric hematologist-oncologist at the Pediatric Hematology Oncology Unit of the Azienda Ospedale Università Padova & member of RADeep Steering Commitee presented “Sickle cell therapies- The Who, What, When and Where” at #ASH25radeepnetwork.eu/
🌍Her presentation highlighted how clinical evidence, patient profiles and preferences, and real-world data can guide these decisions across different ages and geographical settings.
🎯RADeep’s role as a centralized, high-quality real-world data registry is crucial for identifying and characterizing patient cohorts eligible for specific therapeutic strategies.RADeep supports both clinicians and researchers in assessing the question ‘Who, What, When and Where’